We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Delivering Cancer Medication Safely to Its Destination

News   Aug 09, 2019 | Original story from Leibniz-Forschungsinstitut für Molekulare Pharmakologie

 
Delivering Cancer Medication Safely to Its Destination

The new technology enables a simple way of connecting the cytsteine residues (SH) of a tumor-sensing antibody (yellow) to toxic drug molecules. The emerging linker is highly stable during blood circulation and enables therefore a safe transport to the tumor side. Credit: Barth van Rossum/FMP

 
 
Advertisement
 

RELATED ARTICLES

NHS Will Trial Blood Test Designed To Detect > 50 Forms of Cancer

News

A simple blood test that is designed to detect more than 50 forms of cancer will be trialled by the NHS, in efforts to detect signs of the disease much earlier and treat patients before the cancer has progressed to an advanced stage.

READ MORE

Model Designed To Predict Cellular Drug Targets Against COVID-19

News

A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce.

READ MORE

A New Gene Therapy Strategy for Eye Disease

News

Scientists from Trinity have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE